BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27048478)

  • 1. [Characteristics and challenges of rheumatology-specific laboratories in practice].
    von Hinüber U
    Z Rheumatol; 2016 May; 75(4):356-60. PubMed ID: 27048478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status and perspectives of ambulatory rheumatologic health care in Germany : economic structural conditions and motivation of rheumatologists].
    Mittendorf T; Edelmann E; Kekow J; von Hinüber U; Müller-Brodmann W; Graf von der Schulenburg JM
    Z Rheumatol; 2007 Nov; 66(7):611-20. PubMed ID: 17885760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laboratory diagnostics in rheumatology].
    Dörner T; Fleck M
    Z Rheumatol; 2016 May; 75(4):354-5. PubMed ID: 27115696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current aspects of quality assurance].
    Hartung K
    Z Rheumatol; 2016 May; 75(4):367-71. PubMed ID: 27125945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness, cost-utility, and cost-benefit studies in rheumatology: a review of the literature, 2001-2002.
    Tella MN; Feinglass J; Chang RW
    Curr Opin Rheumatol; 2003 Mar; 15(2):127-31. PubMed ID: 12598799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health economic aspects of a stratified medicine for rheumatoid arthritis].
    Frank M; Mittendorf T
    Z Rheumatol; 2013 Feb; 72(1):12-9. PubMed ID: 23223870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survey of rheumatologists in Saxony, Saxony-Anhalt and Thuringia regarding the occupational situation and activities in further education: no way out of the undersupply of rheumatological care].
    Keyßer G; Baerwald CGO; Sieburg M; Boche K; Pfeil A; Kupka TA; Lüthke K; Heldmann F; Oelzner P; Unger L; Aringer M
    Z Rheumatol; 2019 Jun; 78(5):479-485. PubMed ID: 31087134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increasingly appropriate depiction of rheumatology for G-DRG reimbursement 2006].
    Lakomek HJ; Fiori W; Buscham K; Hülsemann J; Köneke N; Liman W; Märker-Hermann E; Roeder N
    Z Rheumatol; 2006 Feb; 65(1):46-8, 50-1. PubMed ID: 16450147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the costs of childhood-onset rheumatic disease?
    Minden K
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):223-40. PubMed ID: 16546054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing wisely: the Canadian Rheumatology Association's list of 5 items physicians and patients should question.
    Chow SL; Carter Thorne J; Bell MJ; Ferrari R; Bagheri Z; Boyd T; Colwill AM; Jung M; Frackowiak D; Hazlewood GS; Kuriya B; Tugwell P;
    J Rheumatol; 2015 Apr; 42(4):682-9. PubMed ID: 25641889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic studies in rheumatology: data, perspectives, challenges.
    Kobelt G
    Rheumatology (Oxford); 2012 Feb; 51(2):208-9. PubMed ID: 22087015
    [No Abstract]   [Full Text] [Related]  

  • 12. [The established rheumatologist in the tension field between health care deficits and cost control in public health].
    Stroehmann I; Karger T
    Z Rheumatol; 1995; 54(4):198-201. PubMed ID: 7495154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives].
    Lakomek HJ; Fiori W; Buscham K; Hülsemann JL; Köneke N; Liman W; Märker-Hermann E; Roeder N
    Z Rheumatol; 2005 Nov; 64(8):557-63. PubMed ID: 16328761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The speciality of rheumatology is on the right path in the G-DRG treatment reimbursement system].
    Lakomek HJ; Gross WL
    Z Rheumatol; 2006 Feb; 65(1):52-3. PubMed ID: 16804995
    [No Abstract]   [Full Text] [Related]  

  • 15. Proposed health price regulations stir up hornet's nest.
    Bateman C
    S Afr Med J; 2008 Jul; 98(7):500, 502, 504. PubMed ID: 18785381
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of specialty care for chronic diseases: a report from an ad hoc committee of the American College of Rheumatology. Committee of the American College of Rheumatology Council on Health Care Research.
    Mayo Clin Proc; 1996 Dec; 71(12):1179-81. PubMed ID: 8945492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OMERACT: economic evaluations and health policy.
    Ruff B
    J Rheumatol; 2001 Mar; 28(3):666-9. PubMed ID: 11296979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016].
    Zink A; Braun J; Gromnica-Ihle E; Krause D; Lakomek HJ; Mau W; Müller-Ladner U; Rautenstrauch J; Specker C; Schneider M
    Z Rheumatol; 2017 Apr; 76(3):195-207. PubMed ID: 28364218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes for rheumatology in the G-DRG system 2005].
    Fiori W; Roeder N; Lakomek HJ; Liman W; Köneke N; Hülsemann JL; Lehmann H; Wenke A
    Z Rheumatol; 2005 Feb; 64(1):58-69. PubMed ID: 15756503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues of consensus and debate for economic evaluation in rheumatology.
    Coyle D; Welch V; Shea B; Gabriel S; Drummond M; Tugwell P
    J Rheumatol; 2001 Mar; 28(3):642-7. PubMed ID: 11296975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.